本文已被：浏览 187次 下载 156次
投稿时间：2025-02-13 网络发布日期：2026-01-27
投稿时间：2025-02-13 网络发布日期：2026-01-27
中文摘要: 宫颈癌术后复发患者预后差。目前对于宫颈癌术后复发的治疗方案尚无统一标准，各国的治疗策略存在差异。早期宫颈 癌以手术为主，对于术后复发患者，由于既往的手术或放化疗史，治疗选择较为困难。随着靶向和免疫治疗研究的深入，其已成为 晚期和复发患者治疗的新方法。本研究综述了宫颈癌术后复发患者的靶向和免疫治疗进展，为该类患者的治疗提供思路。
Abstract:The prognosis of patients with postoperative recurrence of cervical cancer is poor. At present，there is no uniform standard for the treatment of postoperative recurrence of cervical cancer，and there are differences in treatment strategies among different countries. Early cervical cancer is mainly treated by surgery. For patients with postoperative recurrence，it is difficult to choose treatment methods due to previous history of surgery or radiotherapy and chemotherapy. With the deepening of targeted therapy and immunotherapy research，they have become new methods for the treatment of advanced and recurrent patients. This paper reviews the advances of targeted therapy and immunotherapy for postoperative recurrence of cervical cancer，and provides ideas for the treatment of such patients.
keywords: Cervical cancer Postoperation Recurrence Targeted therapy Immunotherapy Anti- angiogenic drugs Immune
checkpoint inhibitors Vaccine Programmed cell death protein T lymphocyte⁃associated molecule
文章编号： 中图分类号：R711 文献标志码：A
基金项目:国家自然科学基金面上项目（82072891）
附件
引用文本：
陈丽萍， 王绍海， 蔡晶.早期宫颈癌术后复发的靶向和免疫治疗进展[J].中国临床研究,2026,39(1):151-155.
陈丽萍， 王绍海， 蔡晶.早期宫颈癌术后复发的靶向和免疫治疗进展[J].中国临床研究,2026,39(1):151-155.